Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autologous Stem Cell Transplantation in Hodgkin Lymphoma—Latest Advances in the Era of Novel Therapies
Yazeed Samara, Matthew Mei
Cancers (2022) Vol. 14, Iss. 7, pp. 1738-1738
Open Access | Times Cited: 11

Showing 11 citing articles:

Immune checkpoint inhibitors in advanced and relapsed/refractory Hodgkin lymphoma: current applications and future prospects
Charles Milrod, Ari Pelcovits, Thomas Ollila
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma
Stephen Daw, Alexander Claviez, Lars Kurch, et al.
JAMA Oncology (2025)
Closed Access
Efficacy of Brentuximab-Vedotin Combined with PD-1 Inhibitors in Relapsed/Refractory Hodgkin Lymphoma with ASCT Consolidation and Maintenance Therapy: A Phase 2 Clinical Trial
Isaac Barrera-Chávez, Juan Carlos Viloria Álvarez, Verónica Zendejas Sánchez, et al.
Indian Journal of Hematology and Blood Transfusion (2025)
Closed Access
Autologous hematopoietic stem cell transplantation conditioning regimens and chimeric antigen receptor T cell therapy in various diseases
Shahzaib Maqbool, Maryam Farhan Baloch, Muhammad Abdul Khaliq Khan, et al.
World Journal of Transplantation (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Herpesvirus Screening in Childhood Hematopoietic Transplant Reveals High Systemic Inflammation in Episodes of Multiple Viral Detection and an EBV Association with Elevated IL-1β, IL-8 and Graft-Versus-Host Disease
Moisés H. Rojas-Rechy, Félix Gaytán‐Morales, Yessica Sánchez-Ponce, et al.
Microorganisms (2022) Vol. 10, Iss. 8, pp. 1685-1685
Open Access | Times Cited: 5
Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study
Rosaria De Filippi, Gianpaolo Marcacci, Enrico Derenzini, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5846-5846
Open Access | Times Cited: 5
Efficacy and safety of stem cell mobilization with etoposide +cytarabine plus G-CSF in poor mobilizers with relapsed or refractory lymphoma
Zhijuan Zhu, Xiaofan Li, Xiaohong Yuan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Evaluation of outcome and safety profile in high-dose BEAM and Benda-EAM chemotherapy with subsequent autologous stem cell transplantation in lymphoma patients
Kinga Krawiec, Piotr Strzałka, Olga Racińska, et al.
Współczesna Onkologia (2024) Vol. 28, Iss. 2, pp. 158-166
Open Access
Hypoxia-induced PD-L1 expression and modulation of muscle stem cell allograft rejection
Jacob Raiten, M. Genevieve, Shane Handelsman, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Stem Cell Transplant for Hodgkin Lymphoma
Sanjeev Sharma
(2023), pp. 259-282
Closed Access
Brentuximab vedotin consolidation therapy after autologous stem cell transplantation in relapsed/refractory classic Hodgkin lymphoma patients in the Czech Republic
Jozef Michalka, Zdeněk Král, Jana Marková, et al.
Onkologie (2023) Vol. 17, Iss. 4, pp. 267-272
Closed Access
Page 1

Scroll to top